BECTON DICKINSON & CO — Director's Dealing 2019

Dec 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2019-12-12

Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-12	Common Stock	M	4236	$242.10	Acquired	19546	Direct
2019-12-12	Common Stock	D	3897	$263.23	Disposed	15649	Direct
2019-12-12	Common Stock	S	339	$263.23	Disposed	15310	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-12	Stock Appreciation Rights	$242.10	M	4236	Disposed	2028-11-26	Common Stock (4236)	Direct

Footnotes

F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.19 through $263.24. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.

F2: The stock appreciation rights vest in four annual installments beginning November 26, 2019.